Dr. Reddy’s diabetes drug’s first phase 3 trial meets target | Alrroya

Dr. Reddy’s diabetes drug’s first phase 3 trial meets target

Monday, 4 January 2010  at  17:11, Bloomberg
Dr. Reddy’s Laboratories Ltd and Rheoscience said the first phase 3 trial of diabetes drug Balaglitazone met its primary target, according to a statement today.








Your comments

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <b> <i> <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options

  • Subscribe to Daily Newsletter More

  • Join Alrroya.com